·  Team deploy Alchemite™ deep learning platform to predict active compounds for malarial drug discovery ·  Successful models selected by Open Source Malaria consortium will be progressed through to design novel compounds for synthesis and testing CAMBRIDGE, UK  – Intellegens, an artificial intelligence (AI) start-up, and, Optibrium™, leading providers of software and services for drug […]

NEW YORK – Schrödinger today announced the appointment of Nancy Thornberry, a biotech executive recognized for her extensive track record in drug discovery and development, to its Board of Directors. Ms. Thornberry, the Chief Executive Officer of Kallyope Inc., brings over 30 years of biopharma leadership to the board. Ms. Thornberry has received several awards for […]

Frankfurt, Germany – Budapest, Hungary, September 20, 2019 Innoplexus announces an official partnership with ChemAxon, getting the most value out from life sciences data. Through the joint venture, Innoplexus will enable big pharma and biotech companies to find and connect information about pharmaceutical compounds from publicly available, or archived enterprise datasets to generate novel ideas. ChemAxon provides […]

Software enhancements offer a complete application for CMC decision support, improvements for analytical data processing and analysis, and a move to 64-bit architecture. Toronto, CANADA—ACD/Labs, an informatics company that develops and commercializes analytical and chemical knowledge management solutions in support of R&D, today announced significant updates across its Spectrus and Percepta platforms to help scientists […]

Software enhancements offer a complete application for CMC decision support, improvements for analytical data processing and analysis, and a move to 64-bit architecture. Toronto, CANADA —ACD/Labs, an informatics company that develops and commercializes analytical and chemical knowledge management solutions in support of R&D, today announced significant updates across its Spectrus and Percepta platforms to help […]